AMYPAD at #AAIC2026

We are pleased to announce our participation in the Alzheimer’s Association International Conference (AAIC) 2026, taking place 12–15 July 2026 in London, United Kingdom. AAIC is the world’s largest international conference dedicated to advancing dementia science and clinical practice, bringing together researchers, clinicians, healthcare professionals and industry partners from around the globe to share the latest scientific discoveries and innovations in Alzheimer’s disease and related dementias. The conference aims to accelerate progress in diagnosis, risk reduction, treatment and patient care through scientific exchange and international collaboration.

At this year’s meeting, AMYPAD and Euro-PAD researchers and collaborators will present findings demonstrating the continued impact of the project on amyloid PET imaging, biomarker development and Alzheimer’s disease research.

We are very much looking forward to the conference and presenting our work! For further information about this event, visit the website: https://aaic.alz.org/

Ahead of the conference, several educational workshops and preconference events featuring AMYPAD and Euro-PAD collaborators will take place on 10–11 July, offering valuable opportunities for learning, networking and scientific exchange.

ISTAART Immersive: Basics of Genetic Analysis on Friday 10 July. The workshop will provide an immersive introduction to the fundamentals of genetic analysis within the framework of brain imaging genetics research. Further information is available here.
ISTAART Immersive: Getting Started with Neuroimaging Analysis on Friday 10 July. The workshop will provide attendees with an interactive, hands-on opportunity to view, process, analyze, and interpret medical imaging data. Further information is available here.
Alzheimer’s Imaging Consortium (AIC) Preconference on Saturday 11 July. It is the a neuroimaging preconference of AAIC, focused on the latest advances in neuroimaging for Alzheimer’s disease and related dementias. Luigi Lorenzini will deliver the opening plenary lecture, “What have we learned from the past year?”. Further information is available here.

Posters at AAIC2026:

Federico Masserini: “Spatial Gradients Of Perfusion And Myelin Density In White Matter Hyperintensities And Surrounding Normal Appearing White Matter” (#3510)
Luigi Lorenzini: “Mapping Micro- And Macro-structural White Matter Pathways Alterations To Amyloid Epicenters” (#7118)
Leo Pieperhoff: “AMYPAD-PNHS: An Open-Access, Pan-european, Multi-site & Multimodal MRI Dataset Of Older Adults Without Dementia” (#4611)
Leo Pieperhoff: “Cortical Gray-white Matter Contrast Alterations Precede Amyloid-β Positivity And Macrostructural Changes In Older Adults” (#2001)
Mathijs Dijsselhof: “Cerebral Blood Flow Decline In Alzheimer’S Disease And Hypertension Using A Healthy Reference Normative Model” (#2647)
Prithvi Arunachalam: “Differential Network Mechanisms Underlying Progression Of Subtype-specific Amyloid Deposition” (#2191)
Prithvi Arunachalam: “Decreased amyloid-related structure-function coupling in preclinical Alzheimer’s disease” (#6442)
Lorenzo Gualco: “Amyloid-vulnerable Cortical Regions Exhibit Higher Baseline Perfusion In A Subjective Cognitive Decline Cohort” (#4232)
Simona Malagò: “Constructing Single-subject Amyloid-PET Brain Connectomes: A Comparison Of Methodological Strategies” (#2979)
Sophie Martin: “Explainable Artificial Intelligence For Automated Amyloid-PET Positivity Classification” (#871)
Emma Luckett: “Biomarker and neuropathology-informed polygenic risk scores link amyloid pathology to early cognitive differences in preclinical AD” (#2760)